Menu
Back to User profile » Mr Rolin L Wade
Papers published by Mr Rolin L Wade:
Lipid-Lowering Therapy Utilization and Dosage Among Patients with Acute Coronary Syndrome Events: A Retrospective Cohort from 12 Community Hospitals
Khatib R, Yeh EJ, Glowacki N, McGuiness CB, Xie H, Wade RL, Kalich BA, Li Y, Rifai A, Sawlani N
Clinical Epidemiology 2023, 15:547-557
Published Date: 4 May 2023
Demographic And Clinical Characteristics Of Patients Prescribed Proprotein Convertase Subtilisin/kexin Type 9 Inhibitor Therapy And Patients Whose Current Lipid-Lowering Therapy Was Modified
Baum SJ, Wade RL, Xiang P, Arellano J, Cerezo Olmos C, Nunna S, Chen CC, Carter CM, Desai NR
Therapeutics and Clinical Risk Management 2019, 15:1325-1332
Published Date: 13 November 2019
Treatment Adherence And Persistence Among HIV-1 Patients Newly Starting Treatment
Hines DM, Ding Y, Wade RL, Beaubrun A, Cohen JP
Patient Preference and Adherence 2019, 13:1927-1939
Published Date: 7 November 2019
Low-density lipoprotein cholesterol outcomes post-non-PCSK9i lipid-lowering therapies in atherosclerotic cardiovascular disease and probable heterozygous familial hypercholesterolemia patients
Chen CC, Rane PB, Hines DM, Patel J, Harrison DJ, Wade RL
Therapeutics and Clinical Risk Management 2018, 14:2425-2435
Published Date: 13 December 2018
Treatment patterns and patient characteristics among early initiators of PCSK9 inhibitors
Hines DM, Rane P, Patel J, Harrison DJ, Wade RL
Vascular Health and Risk Management 2018, 14:409-418
Published Date: 10 December 2018